Positron emission tomography (PET) for cholangiocarcinoma

HPB

Volumn 10, Issue 2, 2008, Pages 120-121

  Breitenstein, S ^a   Apestegui, C ^a   Clavien, P A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cholangiocarcinoma; Computed tomography (CT); Positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER;

BILE DUCT CARCINOMA; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR CELL;

EID: 46649106290     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820801992583     Document Type: Review

References (10)

1. Fong, Y., Jarnagin, W. and Blumgart, LH. (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg, 232, pp. 557-569.
2. Morimoto, Y., Tanaka, Y. Ito, T. et al. (2003) Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobil Pancreat Surg, 10, pp. 432-440.
3. Hany, TF, Steinert, HC Goerres, GW et al. (2002) PET diagnostic accuracy: Improvement with in-lineIPET-CT system: initial results. Radiology, 225, pp. 575-581.
4. Fritscher-Ravens, A., Bohuslavizki, KH Broering, DC et al. (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun, 22, pp. 1277-1285.
5. Kluge, R., Schmidt, F. Caca, K. et al. (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology, 33, pp. 1029-1035.
6. Kato, T., Tsukamoto, E. Kuge, Y. et al. (2002) Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging, 29, pp. 1047-1054.
7. Kim, YJ, Yun, M. Lee, WJ et al. (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging, 30, pp. 1467-1472.
8. Petrowsky, H., Wildbrett, P. Husarik, DB et al. (2006) Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol, 45, pp. 43-50.
9. Moon, CM, Bang, S. Chung, JB et al. (2007) Usefulness of (18)F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. J Gastroenterol Hepatol
10. Jadvar, H., Henderson, RW and Conti, PS. (2007) F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: Computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr, 31, pp. 223-228.